December 23, 2024
CD40L-augmented tumor infiltrating lymphocyte expa...
Lilit Karapetyan’s Abstract Tumor infiltrating lymphocyte (TIL) therapy represents a promising approach for the treatment of patients whose disease does not benefit f...
Lilit Karapetyan’s Abstract Tumor infiltrating lymphocyte (TIL) therapy represents a promising approach for the treatment of patients whose disease does not benefit f...
Alexander Huang’s Abstract Radiation can be used as a vaccine, to increase the effect of immunotherapy. We call this Radvax, which is promising. Even in melanoma pati...
Pilot Proposal – Keiran Smalley, PhD
Nov 22, 2025 PT